Literature DB >> 15905285

Birth of a healthy infant after in vitro oocyte maturation and ICSI in a woman with diminished ovarian response: case report.

Barbro Fridén1, Julius Hreinsson, Outi Hovatta.   

Abstract

In vitro maturation of oocytes (IVM) has been developed as a treatment option for subjects with good prognosis in assisted reproduction. We present successful IVM treatment in connection with a woman from whom low numbers of embryos were obtained after repeated failed conventional IVF cycles. A 35 year old woman, after 5 years infertility and two intrauterine insemination and three conventional IVF cycles, underwent first an IVM cycle with low dose FSH stimulation, and after failure, another natural IVM cycle. Three oocytes were obtained. After 36 h of IVM the oocytes had reached metaphase II stage, and fertilization using ICSI resulted in one 4-cell stage embryo, which was transferred 2 days later. The result was an uneventful pregnancy and birth of a healthy female infant weighing 4150 g. IVM may be an option for women from whom only low numbers of oocytes are obtained after gonadotrophin stimulation.

Entities:  

Mesh:

Year:  2005        PMID: 15905285     DOI: 10.1093/humrep/dei109

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  7 in total

1.  Parthenogenic blastocysts derived from cumulus-free in vitro matured human oocytes.

Authors:  Sohyun L McElroy; James A Byrne; Shawn L Chavez; Barry Behr; Aaron J Hsueh; Lynn M Westphal; Renee A Reijo Pera
Journal:  PLoS One       Date:  2010-06-07       Impact factor: 3.240

2.  Rescue in vitro maturation (IVM) of immature oocytes in stimulated cycles in women with low functional ovarian reserve (LFOR).

Authors:  Ho-Joon Lee; David H Barad; Vitaly A Kushnir; Aya Shohat-Tal; Emanuela Lazzaroni-Tealdi; Yan-Guang Wu; Norbert Gleicher
Journal:  Endocrine       Date:  2015-09-29       Impact factor: 3.633

3.  Live birth following serial vitrification of embryos and PGD for fragile X syndrome in a patient with the premutation and decreased ovarian reserve.

Authors:  Dan Nayot; Jin Tae Chung; Weon-Young Son; Assangla Ao; Mark Hughes; Michael H Dahan
Journal:  J Assist Reprod Genet       Date:  2013-09-06       Impact factor: 3.412

4.  In vitro maturation may prevent the cancellation of in vitro fertilization cycles in poor responder patients: A case report.

Authors:  Ender Yalçınkaya; Eray Calışkan; Ozcan Budak
Journal:  J Turk Ger Gynecol Assoc       Date:  2013-07-10

5.  Human therapeutic cloning (NTSC): applying research from mammalian reproductive cloning.

Authors:  Andrew J French; Samuel H Wood; Alan O Trounson
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

6.  Fertilization and pregnancy potential of immature oocytes from stimulated intracytoplasmic sperm injection cycles.

Authors:  Seung Bi Shin; Jae Won Cho; Sun-Hee Lee; Kwang Moon Yang; Chun Kyu Lim; Hyoung-Song Lee
Journal:  Clin Exp Reprod Med       Date:  2013-03-31

7.  In Vitro Maturation of Oocytes in Women at Risk of Ovarian Hyperstimulation Syndrome-A Prospective Multicenter Cohort Study.

Authors:  Sanne C Braam; Dimitri Consten; Jesper M J Smeenk; Ben J Cohlen; Max H J M Curfs; Carl J C M Hamilton; Sjoerd Repping; Ben W J Mol; Jan Peter de Bruin
Journal:  Int J Fertil Steril       Date:  2019-01-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.